✦ LIBER ✦

Cytotoxic T cell recognition of a human melanoma derived peptide with a carboxyl-terminal alanine-proline sequence

✍ Scribed by Naoko Morioka; Yoshikazu Kikumoto; Dave S.B. Hoon; Donald L. Morton; Reiko F. Irie

Book ID: 116097614
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 1010 KB
Volume: 32
Category: Article
ISSN: 0161-5890
DOI: 10.1016/0161-5890(95)00020-f

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Constitutive transduction of peptide tra

Constitutive transduction of peptide transporter and HLA genes restores antigen processing function and cytotoxic T cell-mediated immune recognition of human melanoma cells

✍ Cathrine A. White; Scott A. Thomson; Leanne Cooper; Peter M. van Endert; Robert 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 161 KB 👁 1 views

## Potentiation of immunogenicity of malignant cells by gene transduction provides a unique opportunity for immune targeting of human cancers in vivo. This approach is undoubtedly influenced by the ability of the malignant cells to process and present endogenously target epitopes on their cell surf

Vaccination with Mage-3a1 Peptide-Pulsed

Vaccination with Mage-3a1 Peptide-Pulsed Mature, Monocyte-Derived Dendritic Cells Expands Specific Cytotoxic T Cells and Induces Regression of Some Metastases in Advanced Stage IV Melanoma

✍ Thurner, B.; Haendle, I.; Roder, C.; Dieckmann, D.; Keikavoussi, P.; Jonuleit, H 📂 Article 📅 1999 🏛 Rockefeller University Press. 🌐 English ⚖ 410 KB

Identification of GP100-derived, melanom

Identification of GP100-derived, melanoma-specific cytotoxic T-lymphocyte epitopes restricted by HLA-A3 supertype molecules by primary in vitro immunization with peptide-pulsed dendritic cells

✍ Ichiro Kawashima; Van Tsai; Scott Southwood; Kazutoh Takesako; Esteban Celis; Al 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 118 KB 👁 2 views

The human melanocyte lineage-specific antigen gp100 contains several epitopes recognized by cytotoxic T lymphocytes (CTL). However, most of the epitopes reported to date are HLA-A2.1-restricted. Despite the high frequency of HLA-A2.1 in melanoma patients, effective population coverage requires the i